Matinas BioPharma Files 8-K on Listing Rule Concerns
Ticker: MTNB · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1582554
| Field | Detail |
|---|---|
| Company | Matinas Biopharma Holdings, Inc. (MTNB) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, regulatory
TL;DR
Matinas BioPharma might be delisted - 8-K filed Jan 6.
AI Summary
Matinas BioPharma Holdings, Inc. filed an 8-K on January 10, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed financial statements and exhibits. The earliest event reported was January 6, 2025. The company is incorporated in Delaware and its principal executive offices are located in Bedminster, New Jersey.
Why It Matters
This filing indicates potential issues with Matinas BioPharma's continued listing on an exchange, which could lead to significant stock price volatility and investor concern.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and investor confidence.
Key Players & Entities
- Matinas BioPharma Holdings, Inc. (company) — Registrant
- January 6, 2025 (date) — Earliest event reported
- January 10, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Bedminster, New Jersey (location) — Principal executive offices
FAQ
What specific listing rule or standard has Matinas BioPharma Holdings, Inc. failed to satisfy?
The filing does not specify the exact listing rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest event date reported in this 8-K filing?
The earliest event reported in this 8-K filing is January 6, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed with the SEC on January 10, 2025.
In which state is Matinas BioPharma Holdings, Inc. incorporated?
Matinas BioPharma Holdings, Inc. is incorporated in Delaware.
What is the business address of Matinas BioPharma Holdings, Inc.?
The business address of Matinas BioPharma Holdings, Inc. is 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921.
Filing Stats: 831 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2025-01-10 17:15:28
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001493152-25-001782.txt ( ) — 242KB
- mtnb-20250106.xsd (EX-101.SCH) — 3KB
- mtnb-20250106_lab.xml (EX-101.LAB) — 33KB
- mtnb-20250106_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MATINAS BIOPHARMA HOLDINGS, INC. Dated: January 10, 2025 By: /s/ Jerome D. Jabbour Name: Jerome D. Jabbour Title: Chief Executive Officer -3-